Upper limb arthroplasty is an increasingly used treatment modality for end-stage joint disease of the shoulder, elbow and wrist. Whilst complications have been reported, the risk of venous thromboembolism has received less attention when compared to the lower limb. Guidance to aid clinical decision-making remains limited. This review aims to ascertain whether venous thromboembolism prophylaxis is beneficial after upper limb major joint replacement surgery.
Methods
A systematic review was performed in April 2019, utilising EMBASE, MEDLINE, Cochrane and Google Scholar. All clinical studies reporting venous thromboembolism incidence and risk reduction (after prophylaxis) in upper limb joint replacement were included.
Results
Twenty-four observational studies were identified. The reported incidence of venous thromboembolism ranged from 0.2% to 16% (weighted mean 0.68%) and 0.2% to 0.8% (weighted mean 0.49%) in shoulder and elbow arthroplasty, respectively. No records for wrist arthroplasty were found. In the literature, baseline venous thromboembolism risk of patients without an operation is reported as 0.5%.
Discussion
There is a lack of good quality evidence regarding the risks and benefits of venous thromboembolism prophylaxis in upper limb major joint replacement surgery. We recommend further research, ideally formal randomised controlled trials to guide recommendations. Although venous thromboembolism is rare in upper limb surgery, surgeons should remain vigilant to this possibility.
BlannADLipGYH. Venous thromboembolism. Br Med J2006; 332: 215–219.
3.
SøgaardKKSchmidtMPedersenL, et al.30-Year mortality after venous thromboembolism. Circulation2014; 130: 829–836.
4.
GibbsHFletcherJBlomberyP, et al.Venous thromboembolism prophylaxis guideline implementation is improved by nurse directed feedback and audit. Thromb J2011; 9: 7–7.
5.
LauBDHautER. Practices to prevent venous thromboembolism: a brief review. BMJ Qual Saf2014; 23: 187–195.
6.
KotaskaA. Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines. Thromb J2018; 16: 25–25.
7.
BarkerRCMarvalP. Venous thromboembolism: risks and prevention. Contin Educ Anaesth Crit Care Pain2011; 11: 18–23.
8.
FlevasDAMegaloikonomosPDDimopoulosL, et al.Thromboembolism prophylaxis in orthopaedics: an update. EFORT Open Rev2018; 3: 136–148.
HigginsJPTAltmanDGGøtzschePC, et al.The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Brit Med J2011; 343: d5928–d5928.
15.
ThomasBHCiliskaDDobbinsM, et al.A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs2004; 1: 176–184.
16.
NorrisTRIannottiJP. Functional outcome after shoulder arthroplasty for primary osteoarthritis: a multicenter study. J Shoulder Elbow Surg2002; 11: 130–135.
17.
JohnWSperlingRHC. Pulmonary embolism following shoulder arthroplasty. J Bone Joint Surg Am2002; 84: 1939–1941.
18.
AnjumSNButtMS. Treatment of comminuted proximal humerus fractures with shoulder hemiarthroplasty in elderly patients. Acta Orthop Belg2005; 71: 388–395. http://www.ncbi.nlm.nih.gov/pubmed/16184991.
19.
LymanSShermanSCarterTI, et al.Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty. Clin Orthop Relat Res2006; 448: 152–156.
20.
HoxieSCSperlingJWCofieldRH. Pulmonary embolism after operative treatment of proximal humeral fractures. J Shoulder Elbow Surg2007; 16: 782–783.
21.
KrishnanSGNowinskiRJHarrisonD, et al.Humeral hemiarthroplasty with biologic resurfacing of the glenoid for glenohumeral arthritis: two to fifteen-year outcomes. J Bone Joint Surg Am2007; 89: 727–734.
22.
WillisAAWarrenRFCraigEV, et al.Deep vein thrombosis after reconstructive shoulder arthroplasty: a prospective observational study. J Shoulder Elbow Surg2009; 18: 100–106.
23.
LenarzCShishaniYMcCrumC, et al.Is reverse shoulder arthroplasty appropriate for the treatment of fractures in the older patient?: Early observations. Clin Orthop Relat Res2011; 469: 3324–3331.
24.
FarngEZingmondDKrenekL, et al.Factors predicting complication rates after primary shoulder arthroplasty. J Shoulder Elbow Surg2011; 20: 557–563.
25.
JamesonSSJamesPHowcroftDWJ, et al.Venous thromboembolic events are rare after shoulder surgery: analysis of a national database. J Shoulder Elbow Surg2011; 20: 764–770.
26.
NavarroRAInacioMCSBurkeMF, et al.Risk of thromboembolism in shoulder arthroplasty: effect of implant type and traumatic indication. Clin Orthop Relat Res2013; 471: 1576–1581.
27.
WronkaKSPritchardMSinhaA. Incidence of symptomatic venous thrombo-embolism following shoulder surgery. Int Orthop2014; 38: 1415–1418.
28.
DayJSRamseyMLLauE, et al.Risk of venous thromboembolism after shoulder arthroplasty in the Medicare population. J Shoulder Elbow Surg2015; 24: 98–105.
29.
KusnezovNDunnJCParadaSA, et al.Clinical outcomes of anatomical total shoulder arthroplasty in a young, active population. Am J Orthop2016; 45: E273–E282. http://www.ncbi.nlm.nih.gov/pubmed/27552465.
30.
TashjianRZLillyDTIsaacsonAM, et al.Incidence of and risk factors for symptomatic venous thromboembolism after shoulder arthroplasty. Am J Orthop2016; 45: E379–E385. http://www.ncbi.nlm.nih.gov/pubmed/27737296.
31.
SingDCTangtiphaiboontanaJMaCB, et al.Incidence and risk factors for venous thromboembolic events after open shoulder surgery. J Shoulder Elbow Arthroplast2017; 1: 247154921774024–247154921774024.
32.
KochOdu PlessisAOlorunjuS, et al.Incidence of deep vein thrombosis following shoulder replacement surgery: a prospective study. SA Orthop J2017; 16: 33–39.
33.
BelmontPJKusnezovNADunnJC, et al.Predictors of hospital readmission after total shoulder arthroplasty. Orthopedics2017; 40: e1–e10.
34.
LovyAJKeswaniABeckC, et al.Risk factors for and timing of adverse events after total shoulder arthroplasty. J Shoulder Elbow Surg2017; 26: 1003–1010.
35.
CraigRSLaneJCECarrAJ, et al.Serious adverse events and lifetime risk of reoperation after elective shoulder replacement: population based cohort study using hospital episode statistics for England. Brit Med J2019; 364: 1298–1298.
36.
DuncanSFMSperlingJWMorreyBF. Prevalence of pulmonary embolism after total elbow arthroplasty. J Bone Joint Surg Am2007; 89: 1452–1453.
37.
KrenekLFarngEZingmondD, et al.Complication and revision rates following total elbow arthroplasty. J Hand Surg Am2011; 36: 68–73.
38.
JenkinsPJWattsACNorwoodT, et al.Total elbow replacement: outcome of 1,146 arthroplasties from the Scottish Arthroplasty Project. Acta Orthop2013; 84: 119–123.
39.
Zhou H, Orvets ND, Merlin G, et al. Total Elbow Arthroplasty in the United States: Evaluation of Cost, Patient Demographics, and Complication Rates. Orthop Rev (Pavia). 2016; 8: 6113. DOI: 10.4081/or.2016.6113.
40.
RobertsDCWarwickDJ. Venous thromboembolism following elbow, wrist and hand surgery: a review of the literature and prophylaxis guidelines. J Hand Surg2014; 39: 306–312.
41.
AzboyIBarrackRThomasAM, et al.Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions. Bone Joint J2017; 99-B: 1420–1430.
42.
AndersonDRDunbarMMurnaghanJ, et al.Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med2018; 378: 699–707.
43.
SweetlandSGreenJLiuB, et al.Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. Brit Med J2009; 339: b4583–b4583.
LeeSHwangJ-IKimY, et al.Venous thromboembolism following hip and knee replacement arthroplasty in Korea: a nationwide study based on Claims Registry. J Korean Med Sci2016; 31: 80–88.
46.
BahlVHuHMHenkePK, et al.A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg2010; 251: 344–350.
47.
van ReinNBiedermannJSvan der MeerFJM, et al.Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis. J Thromb Haemost2017; 15: 1386–1391.
Sachdeva A, Dalton M and Lees T. Graduated compression stockings for prevention of deep vein thrombosis. Cochrane Database of Systematic Reviews 2018; 11: CD001484. DOI: 10.1002/14651858.CD001484.pub4.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
